The disappearing response
A drug that gives a strong effect on Monday can give a weaker one by Friday at the very same dose. This is tolerance: the system has adapted so that more drug is now needed for the same result — the whole dose–response curve slides to the right, or its ceiling drops. Tolerance is one of the most clinically important phenomena in all of pharmacodynamics, and it has several distinct mechanisms.
- Desensitization at the receptor. Within minutes of heavy agonist exposure, many receptors get chemically tagged (phosphorylated) and uncoupled from their signaling machinery — see desensitization. The receptor is still there but stops responding.
- Receptor downregulation. Over hours to days the cell internalizes and degrades receptors, lowering their number. Now even a maximal dose has fewer receptors to act on, eating into any receptor reserve.
- Physiological / counter-regulatory adaptation. The body fights back through other systems, an effect related to functional antagonism — a second pathway pushing the opposite way blunts the net response without touching the drug's own target.
Time enters the binding itself
So far we have treated binding as a snapshot — an equilibrium number like affinity or IC50. But binding is dynamic: a drug associates with and dissociates from its target continuously, and the rates matter. Binding kinetics describes those on- and off-rates. The headline quantity for medicinal chemists is residence time: how long, on average, the drug stays bound before it falls off, set mainly by the off-rate.
Residence time can decouple effect from plasma concentration in a useful way. A drug with a very long residence time may keep working long after it has mostly cleared the bloodstream, because it is still gripping the target. That can let a short-half-life molecule act like a long-acting one — and it changes how you read receptor occupancy over a dosing interval. Two drugs with identical equilibrium affinity can behave very differently in the body if one lets go in seconds and the other in hours.
Tying exposure to effect: PK/PD
All of this — the curve, occupancy, residence time, tolerance — comes together in PK/PD modeling. Pharmacokinetics (PK) tells you the drug concentration over time; pharmacodynamics (PD) tells you the effect at a given concentration. Stitch them and you can predict the *effect over time* from a dose, including delays, plateaus, and the slow erosion of tolerance.
This is where pharmacodynamics stops being a set of static curves and becomes a story across time — the version a real drug lives out in a real patient. A candidate is judged not just on a clean dose–response in a dish, but on whether its effect holds up dose after dose, day after day, in a body that is busy adapting. Holding the whole picture in mind — potency, efficacy, selectivity, the therapeutic window, and the way effects rise and fade — is what it means to understand what a drug does.